The Vox Markets Podcast / Cathal Friel & Jeremy Skillington of Poolbeg Pharma discuss progress on their lead asset POLB 001

Our new player has been redesigned to fit in better wherever you embed it. Feedback is welcome on our support site.
You can still use our old player if you prefer.